<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Fentora lawsuits are reviewed as FDA issues warning</title>
	<atom:link href="http://www.youhavealawyer.com/blog/2007/09/27/fentora-lawsuits/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.youhavealawyer.com/blog/2007/09/27/fentora-lawsuits/</link>
	<description>Saiontz, Kirk &#038; Miles personal injury and medical malpractice lawyers.</description>
	<pubDate>Fri, 25 Jul 2008 03:18:39 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>By: FDA Concerned about Fentora Problems with Overdose and Death if Wider Use Allowed &#124; Legal News &#38; Updates Blog - Saiontz, Kirk &#38; Miles</title>
		<link>http://www.youhavealawyer.com/blog/2007/09/27/fentora-lawsuits/#comment-46256</link>
		<dc:creator>FDA Concerned about Fentora Problems with Overdose and Death if Wider Use Allowed &#124; Legal News &#38; Updates Blog - Saiontz, Kirk &#38; Miles</dc:creator>
		<pubDate>Mon, 05 May 2008 12:08:18 +0000</pubDate>
		<guid isPermaLink="false">http://www.youhavealawyer.com/blog/2007/09/27/fentora-lawsuits/#comment-46256</guid>
		<description>[...] Cephalon, Inc. is attempting to seek FDA approval for Fentora tablets to be used for sudden pain in non-cancer patients who have already developed a tolerance to opioids. An FDA advisory panel is scheduled to meet on Tuesday to review the subject. Documents released in advance of the meeting indicate that the FDA is concerned that wider approval could have a &#8220;devastating effect&#8221; due to the risk of Fentora overdose and abuse. [...]</description>
		<content:encoded><![CDATA[<p>[...] Cephalon, Inc. is attempting to seek FDA approval for Fentora tablets to be used for sudden pain in non-cancer patients who have already developed a tolerance to opioids. An FDA advisory panel is scheduled to meet on Tuesday to review the subject. Documents released in advance of the meeting indicate that the FDA is concerned that wider approval could have a &#8220;devastating effect&#8221; due to the risk of Fentora overdose and abuse. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
